)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
Shanghai Henlius Biotech
Shanghai Henlius Biotech (2696) investor relations material
Shanghai Henlius Biotech 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary15 Jan, 2026
Corporate overview and global footprint
Four products approved by US FDA, seven by China NMPA, and four by EU EMA; over 950,000 patients benefited globally.
30+ ongoing clinical trials, 50+ early-stage assets, and 4,000 global employees.
Manufacturing capacity of 80,000 liters in China; 1,600 oncology commercialization professionals in China and 20 overseas sales partners.
Products sold in over 60 countries and regions.
Clinical pipeline highlights and trial progress
Serplulimab approved for multiple indications in China and EU; global phase III studies ongoing with key data readouts expected next year.
HLX22, a novel HER2 mAb, in global phase III trials; shows superior safety and efficacy compared to Keynote-811 and HERIZON studies.
HLX43 (PD-L1 ADC) demonstrates high ORR in solid tumors, especially non-small cell lung cancer and cervical cancer; global phase III trials to start this year.
HLX07 (EGFR mAb) shows promising PFS in squamous non-small cell lung cancer; phase II/III multinational studies to begin this year.
Upcoming milestones and regulatory plans
Anticipated regulatory approvals for serplulimab in perioperative gastric cancer in China and non-small cell lung cancer in the EU.
BLA filings for serplulimab in the US for small cell lung cancer (extensive and limited stage) planned this year.
HLX22 data readout for HER2 low breast cancer (China) and HLX43 pivotal phase III studies for non-small cell lung cancer expected.
Multiple data publications and readouts at ASCO for various indications, including ESCC, NPC, and ovarian cancer.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Shanghai Henlius Biotech earnings date
H2 202523 Mar, 2026
Shanghai Henlius Biotech
Next Shanghai Henlius Biotech earnings date
H2 202523 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Shanghai Henlius Biotech Inc is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of biologic drugs, particularly biosimilars and monoclonal antibody therapies. The company’s product portfolio addresses a range of therapeutic areas, including oncology, autoimmune diseases, and infectious diseases. Henlius operates advanced manufacturing facilities and research centers, employing innovative biotechnology to support its drug development pipeline and expand access to biologic treatments. The company is headquartered in Shanghai, China, and its shares are listed on the HKEX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage